{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:27:09Z","timestamp":1784708829909,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Yellow fever vaccine exists for over 80\u2009years and is considered to be relatively safe. However, in rare cases it can produce serious neurotropic and viscerotropic complications. We report a case of a patient who presented both viscerotropic and neurological manifestations after yellow fever vaccination.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We describe the case of a 37\u2009years old man who developed after the yellow fever vaccination a yellow fever vaccine-associated viscerotropic disease followed by acute uveitis. Prolonged detection of yellow fever RNA in blood and urine was consistent with yellow fever vaccine-associated adverse event. The final outcome was good, although with persistent fatigue over a few months.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Even if the yellow fever vaccine is relatively safe, physicians should be aware of its possible serious adverse effects.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-4838-x","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T18:03:10Z","timestamp":1581357790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4389-6305","authenticated-orcid":false,"given":"Lev","family":"Volkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Grard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Edouard","family":"Bollaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume A.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Cravoisy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Nace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Courte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Marnai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Leparc-Goffart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Gibot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"issue":"RR-7","key":"4838_CR1","first-page":"1","volume":"59","author":"JE Staples","year":"2010","unstructured":"Staples JE, Gershman M, Fischer M, Centers for Disease Control and Prevention (CDC). Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2010;59(RR-7):1\u201327.","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"key":"4838_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","volume":"64","author":"TP Monath","year":"2015","unstructured":"Monath TP, Vasconcelos PFC. Yellow fever. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2015;64:160\u201373. https:\/\/doi.org\/10.1016\/j.jcv.2014.08.030.","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"issue":"6","key":"4838_CR3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1084\/jem.65.6.787","volume":"65","author":"M Theiler","year":"1937","unstructured":"Theiler M, Smith HH. The use of yellow fever virus modified by in vitro cultivation for human immunization. J Exp Med. 1937;65(6):787\u2013800.","journal-title":"J Exp Med"},{"issue":"4","key":"4838_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1586\/14760584.4.4.553","volume":"4","author":"TP Monath","year":"2005","unstructured":"Monath TP. Yellow fever vaccine. Expert Rev Vaccines. 2005;4(4):553\u201374. https:\/\/doi.org\/10.1586\/14760584.4.4.553.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"4838_CR5","doi-asserted-by":"publisher","first-page":"e2730","DOI":"10.1371\/journal.pntd.0002730","volume":"8","author":"C Escadafal","year":"2014","unstructured":"Escadafal C, et al. Rapid molecular assays for the detection of yellow fever virus in low-resource settings. PLoS Negl Trop Dis. 2014;8(3):e2730. https:\/\/doi.org\/10.1371\/journal.pntd.0002730.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"4838_CR6","doi-asserted-by":"publisher","first-page":"taw045","DOI":"10.1093\/jtm\/taw045","volume":"23","author":"Nicole P. Lindsey","year":"2016","unstructured":"Lindsey NP, Rabe IB, Miller ER, Fischer M, Staples JE. Adverse event reports following yellow fever vaccination, 2007\u201313. J Travel Med. 2016;23(5). https:\/\/doi.org\/10.1093\/jtm\/taw045.","journal-title":"Journal of Travel Medicine"},{"issue":"10","key":"4838_CR7","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","volume":"25","author":"AW McMahon","year":"2007","unstructured":"McMahon AW, et al. Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases. Vaccine. 2007;25(10):1727\u201334. https:\/\/doi.org\/10.1016\/j.vaccine.2006.11.027.","journal-title":"Vaccine"},{"issue":"33","key":"4838_CR8","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1016\/j.vaccine.2012.04.067","volume":"30","author":"MD Gershman","year":"2012","unstructured":"Gershman MD, et al. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2012;30(33):5038\u201358. https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.067.","journal-title":"Vaccine"},{"issue":"5","key":"4838_CR9","doi-asserted-by":"publisher","first-page":"919","DOI":"10.4269\/ajtmh.2010.10-0001","volume":"82","author":"TP Monath","year":"2010","unstructured":"Monath TP. Suspected yellow fever vaccine-associated Viscerotropic adverse events (1973 and 1978), United States. Am J Trop Med Hyg. 2010;82(5):919\u201321. https:\/\/doi.org\/10.4269\/ajtmh.2010.10-0001.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"4838_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/viro.2001.1168","volume":"290","author":"R Galler","year":"2001","unstructured":"Galler R, et al. Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology. 2001;290(2):309\u201319. https:\/\/doi.org\/10.1006\/viro.2001.1168.","journal-title":"Virology"},{"issue":"11","key":"4838_CR11","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1086\/587844","volume":"197","author":"H-G Bae","year":"2008","unstructured":"Bae H-G, et al. Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. J Infect Dis. 2008;197(11):1577\u201384. https:\/\/doi.org\/10.1086\/587844.","journal-title":"J Infect Dis"},{"issue":"9276","key":"4838_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","volume":"358","author":"PF Vasconcelos","year":"2001","unstructured":"Vasconcelos PF, et al. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet. 2001;358(9276):91\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(01)05326-0.","journal-title":"Lancet"},{"issue":"9276","key":"4838_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","volume":"358","author":"M Martin","year":"2001","unstructured":"Martin M, et al. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet Lond Engl. 2001;358(9276):98\u2013104.","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"4838_CR14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.4269\/ajtmh.2010.09-0570","volume":"82","author":"RW Douce","year":"2010","unstructured":"Douce RW, Freire D, Tello B, V\u00e1squez GA. A case of yellow fever vaccine\u2013associated Viscerotropic disease in Ecuador. Am J Trop Med Hyg. 2010;82(4):740\u20132. https:\/\/doi.org\/10.4269\/ajtmh.2010.09-0570.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"4838_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1708-8305.2008.00209.x","volume":"15","author":"J Mu\u00f1oz","year":"2008","unstructured":"Mu\u00f1oz J, et al. Yellow fever\u2013associated Viscerotropic disease in Barcelona, Spain. J Travel Med. 2008;15(3):202\u20135. https:\/\/doi.org\/10.1111\/j.1708-8305.2008.00209.x.","journal-title":"J Travel Med"},{"issue":"2","key":"4838_CR16","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1128\/JCM.01775-10","volume":"49","author":"C Domingo","year":"2011","unstructured":"Domingo C, et al. Detection of yellow fever 17D genome in urine. J Clin Microbiol. 2011;49(2):760\u20132. https:\/\/doi.org\/10.1128\/JCM.01775-10.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4838_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/09273948.2018.1510529","volume":"27","author":"Ana Luiza Biancardi","year":"2018","unstructured":"Biancardi AL, de Moraes HV. Anterior and intermediate uveitis following yellow fever vaccination with fractional dose: case reports. Ocul Immunol Inflamm. 2018:1\u20133. https:\/\/doi.org\/10.1080\/09273948.2018.1510529.","journal-title":"Ocular Immunology and Inflammation"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4838-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-4838-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4838-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T01:08:34Z","timestamp":1612832914000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-4838-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4838"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-4838-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"28 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}